Archive for October, 2008
With three specially focused sessions planned, the IOF World Congress on Osteoporosis will offer orthopaedic surgeons a unique opportunity to discuss the specific clinical challenges of fracture healing and repair, and learn how best practice is applied in different regions of the world. Details of the orthopaedic sessions are available below.
More: continued here
Cardo Medical (OTC Bulletin Board: CKST), a company engaged in the development of orthopedic medical devices, announces the FDA 510k clearance of its Align 360 Total Knee System. The Align 360 Total Knee System is planned for commercial release during the second quarter of 2009. Cardo Medical’s innovative Total Knee System is the flagship product within its Align 360 platform which has already received FDA clearance for its Uni-Compartmental and Patello-Femoral systems.
More: continued here
A large scale study led by renowned osteoporosis researcher Dr. Jianhua Wang and presented at the recent 6th International Conference on Bone and Mineral Research in Hohhot, China affirms the precision and accuracy of CompuMed Inc.’s OsteoGram® system for low cost osteoporosis screening. Dr.
More: continued here
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced results from its pilot clinical study evaluating the safety and clinical utility of Augment Injectable Bone Graft (AIBG, formerly known as GEM OS2) for the treatment of closed distal radius (wrist) fractures.
More: continued here
The first comprehensive orthopedic program in the Chicago area to address hip pain in children and young adults has been developed by orthopedic physicians at Rush University Medical Center. The goal of the Healthy Hip Program is to preserve the hip and help patients return to a full, active life. It offers alternatives to hip replacement to a patient population that suffers from chronic hip pain.
More: continued here
Ivera Medical Corporation, a San Diego (CA) based medical device company today announced that it received FDA 510(k) clearance to begin marketing its Curos™ Port Protector, an innovative medical device that decontaminates needleless intravenous (I.V.) access ports, and helps to prevent touch and airborne contamination.
More: continued here
The IOF World Congress on Osteoporosis, the largest scientific conference devoted primarily to osteoporosis, will open on December 3rd in Bangkok with a special session focused on four key topics in nutrition and bone health. Professor Cyrus Cooper, Director of the MRC Epidemiology Resource Centre at the University of Southampton; and Norman Collisson Chair of Musculoskeletal Sciences at the University of Oxford, will speak on the developmental origins of osteoporosis.
More: continued here
Centinel Spine, Inc. announced today that it has initiated US Alpha Site evaluation of the STALIF C™ NO PROFILE™ Stand Alone Cervical IBF Device for single level use in the treatment of cervical degenerative disc disease. The Company expects STALIF C™ to be available in early 2009, enabling spine surgeons to use the technology as an IBF device without supplementary fixation.
More: continued here
According to a study published in the Annals of the Rheumatic Diseases, women who have many children, used hormone replacement therapy, and had early puberty are more likely to have surgery performed on their joints - especially on their knees. Researchers from the United Kingdom studied 1.3 million middle-aged UK women who took part in the Million Women Study.
More: continued here
The US Food and Drug Administration (FDA) has written warning letters to drug company Bayer HealthCare about two over the counter (OTC) aspirins that contain supplements and claim to be effective not only for pain relief but against heart disease, and this constitutes a use for which the drugs have not been given approval and therefore makes them illegal said the agency in a statement on Tuesday.
More: continued here





